Sandbox: ATL: Difference between revisions
Jump to navigation
Jump to search
(Replaced content with "high lactate dehydrogenase (LDH) high leukemic counts hypercalcemia poor clinical performance status") |
No edit summary |
||
| Line 1: | Line 1: | ||
Most patients with medulloblastoma are initially asymptomatic. If left untreated, most of the patients with medulloblastoma will develop ataxia, nystagmus, and positional dizziness within a few months. | |||
The clinical course is aggressive with a median survival of less than 12 months in the acute and lymphoma forms. | |||
high lactate dehydrogenase (LDH) | high lactate dehydrogenase (LDH) | ||
high leukemic counts | high leukemic counts | ||
hypercalcemia | hypercalcemia | ||
poor clinical performance status | poor clinical performance status | ||
Revision as of 18:47, 24 January 2016
Most patients with medulloblastoma are initially asymptomatic. If left untreated, most of the patients with medulloblastoma will develop ataxia, nystagmus, and positional dizziness within a few months. The clinical course is aggressive with a median survival of less than 12 months in the acute and lymphoma forms.
high lactate dehydrogenase (LDH) high leukemic counts hypercalcemia poor clinical performance status